INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Emvenio mobile]( "Debunking 5 Misconceptions About Community-Based Research Sites")
Debunking 5 Misconceptions About Community-Based Research SitesBy confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.
-
![GettyImages-1386486759 EDC]( "Avoid Database Go-Live Delays With The Right EDC System")
Avoid Database Go-Live Delays With The Right EDC SystemIf you are looking to speed up your start-up process, selecting a reliable EDC System is key.
-
![Data analyst using spreadsheet-GettyImages-2170289960]( "A Mission To Expand Recruitment Territory")
A Mission To Expand Recruitment TerritoryLearn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
-
![Cancer patient consulting with doctor-GettyImages-1217056000]( "Tips And Tricks For Developing Rare Cancer Clinical Trials")
Tips And Tricks For Developing Rare Cancer Clinical TrialsConducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.
-
Data Key In Addressing Patient Recruitment Challenges6/19/2025
Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.
-
Data Privacy And Trust In China's Clinical Trials2/4/2026
China’s evolving privacy laws are reshaping how global trials operate. Sponsors that prioritize transparency and participant confidence can meet compliance demands while building lasting trust.
-
Biotech Landscape Continues To Shift9/18/2025
Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.
-
Unlocking Recruitment Potential In Trial-Naïve Sites4/17/2025
Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.
-
Practical ICH E6(R3) Oversight For Your Centralized Monitoring Strategy3/17/2026
Bridge the gap between fragmented data and ICH E6(R3) compliance. Learn to use unified data signals to catch consent errors and enrollment delays before they trigger audit findings.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Brain]( "Trialtrove: The Most Trusted, Comprehensive & Reliable Clinical Trial Intelligence")
Trialtrove is the industry's go-to resource to support and inform clinical trial strategy, design and execution. Our expert analysts provide insights into trial timing benchmarks, enrollment successes and failures, accrual details and study results.
-
![Speaking meeting]( "Biometrics")
Advancing a novel therapy through clinical development is complicated. Not all therapies make it to the patients that need them.
-
![GettyImages-1446401288-preventative-maintenance-protection-coverage-checkmark-laptop]( "Dynamic RTSM Featuring Configurable, Pre-Validated Components")
Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Integrated Programs To Bridge Molecules From Discovery Into Clinical Development")
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
![Doctor talking to patient-GettyImages-1330555438]( "Supporting Patients For Better Clinical Trials")
From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.
